Research News From November 26, 2006
advertisement
- New data from NIH lab confirms protocol to reverse type 1 diabetes in mice. However, see also Comment on Papers by Chong et al., Nishio et al., and Suri et al. on Diabetes Reversal in NOD Mice (PDF), Response to Comment on Chong et al. on Diabetes Reversal in NOD Mice (PDF), Response to Comment on Nishio et al. on Diabetes Reversal in NOD Mice (PDF), and Response to Comment on Suri et al. on Diabetes Reversal in NOD Mice (PDF).
- Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Free full text available in PDF format. See also Human Bone Marrow Cells Repair Mouse Islets.
- Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus.
- Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration.
- Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
- Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
- Pasteur-Weizmann/Servier prize winners advance diabetes therapy R&D.
- Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study.
- Treatment of new-onset type 1 diabetes with peptide DiaPep277(R) is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.
- Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.
- Renoprotective effects of tea catechin in streptozotocin-induced diabetic rats.
- Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy.
